Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
342/2021 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2021/824 of 21 May 2021 amending Implementing Regulations (EU) No 540/2011 and (EU) No 820/2011 as regards the conditions of approval of the active substance terbuthylazine
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2021/824 frá 21. maí 2021 um breytingu á framkvæmdarreglugerðum (ESB) nr. 540/2011 og (ESB) nr. 820/2011 að því er varðar skilyrði fyrir samþykki fyrir virka efninu terbútýlasíni
Durchführungsverordnung (EU) 2021/824 der Kommission vom 21. Mai 2021 zur Änderung der Durchführungsverordnungen (EU) Nr. 540/2011 und (EU) Nr. 820/2011 hinsichtlich der Bedingungen für die Genehmigung des Wirkstoffs Terbuthylazin
History
11.12.2021
Adopted JCD confirmed entry into force date
11.12.2021
Compliance date in the EEA
10.12.2021
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
25.08.2021
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
21.05.2021
Adoption date in the EU
14.06.2021
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.